Health Condition 1: B20- Human immunodeficiency virus [HIV]disease
Conditions
Interventions
Intervention1: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
Dr Ritvik Jain
Eligibility
Inclusion criteria
Inclusion criteria: 1. HIV Positive individuals 2. On stable cART for a minimum of 1 year
Exclusion criteria
Exclusion criteria: 1. Less than 30 years of age 2. History/Treatment for dyslipidemia 3. History/Treatment for cardiovascular disease 4. CKD/CLD/Malignancy 5. Endocrinal disorders 6. Pregnant/Breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine whether it is statistically significant to use LAP index as a marker to assess cardiovascular risk and insulin resistanceTimepoint: 18 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To determine whether it was statistically significant to correlate LAP index with risk categories of Framingham risk scoreTimepoint: 18 months;To determine whether LAP index & Framingham risk scores are correlated in PLHIV with metabolic syndromeTimepoint: 18 months;To determine whether LAP index was as accurate as HOMA IR in assessing insulin resistanceTimepoint: 18 months | — |
Countries
India
Contacts
Public ContactDr Satish B Rao
Kasturba Medical College, Mangalore
Outcome results
None listed